Filing metadata

Accession number
0001326389-22-000010
Form type
Form 3
Filer
Calidi Biotherapeutics, Inc.
CIK
CIK 1855485
Filed
Sep 26, 2022
Reporting period
Sep 16, 2022
Description
Initial ownership

Explore SEC Filings Hub